These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 32312681)

  • 1. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
    Xiao J; Glasgow E; Agarwal S
    Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Cancer Models in Zebrafish.
    Casey MJ; Stewart RA
    Trends Cancer; 2020 May; 6(5):407-418. PubMed ID: 32348736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zebrafish patient avatars in cancer biology and precision cancer therapy.
    Fazio M; Ablain J; Chuan Y; Langenau DM; Zon LI
    Nat Rev Cancer; 2020 May; 20(5):263-273. PubMed ID: 32251397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine.
    Di Franco G; Usai A; Funel N; Palmeri M; Montesanti IER; Bianchini M; Gianardi D; Furbetta N; Guadagni S; Vasile E; Falcone A; Pollina LE; Raffa V; Morelli L
    World J Gastroenterol; 2020 Jun; 26(21):2792-2809. PubMed ID: 32550755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer cell transplantation in zebrafish: From translational research to personalized medicine].
    Raby L; Völkel P; Le Bourhis X; Angrand PO
    Bull Cancer; 2020 Jan; 107(1):30-40. PubMed ID: 31466696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents.
    Li X; Li M
    Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish xenograft models of cancer and metastasis for drug discovery.
    Brown HK; Schiavone K; Tazzyman S; Heymann D; Chico TJ
    Expert Opin Drug Discov; 2017 Apr; 12(4):379-389. PubMed ID: 28277839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Next generation zebrafish-based drug discovery and precision medicine].
    Tanaka T; Koiwa J
    Nihon Yakurigaku Zasshi; 2019; 154(2):78-83. PubMed ID: 31406047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery.
    Weng T; Jenkins BJ; Saad MI
    Methods Mol Biol; 2024; 2806():19-30. PubMed ID: 38676793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer.
    Altunel E; Roghani RS; Chen KY; Kim SY; McCall S; Ware KE; Shen X; Somarelli JA; Hsu DS
    BMC Cancer; 2020 Jun; 20(1):592. PubMed ID: 32580713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening.
    Jung DW; Oh ES; Park SH; Chang YT; Kim CH; Choi SY; Williams DR
    Mol Biosyst; 2012 Jul; 8(7):1930-9. PubMed ID: 22569777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Pharmacology Models for Cancer Target Research.
    Chen D; An X; Ouyang X; Cai J; Zhou D; Li QX
    Methods Mol Biol; 2019; 1953():183-211. PubMed ID: 30912023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
    Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
    Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
    Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
    Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models.
    Costa B; Estrada MF; Mendes RV; Fior R
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.
    Hason M; Bartůněk P
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31731811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer.
    Somarelli JA; Roghani RS; Moghaddam AS; Thomas BC; Rupprecht G; Ware KE; Altunel E; Mantyh JB; Kim SY; McCall SJ; Shen X; Mantyh CR; Hsu DS
    Mol Cancer Ther; 2020 Dec; 19(12):2516-2527. PubMed ID: 33158998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
    Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
    Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.